Randomised controlled trials and other prospective clinical studies for novel medical
interventions in people with diabetes have traditionally reported HbA 1c as the measure of …

Improvements in sensor accuracy, greater convenience and ease of use, and expanding
reimbursement have led to growing adoption of continuous glucose monitoring (CGM) …

Inclusion of continuous glucose monitoring (CGM) targets for children, adolescents, and
young adults< 25 years. Emphasis on individualized care plans that make use of effective …

Objective To provide evidence-based recommendations regarding the use of advanced
technology in the management of persons with diabetes mellitus to clinicians, diabetes-care …

Technological advances have had a major effect on the management of type 1 diabetes. In
addition to blood glucose meters, devices used by people with type 1 diabetes include …

OBJECTIVE Insulin delivery methods, glucose-monitoring modalities, and related outcomes
were examined in a large, international, diverse cohort of children and adolescents with type …

Importance Hybrid closed-loop (HCL) therapy has improved glycemic control in children and
adolescents with type 1 diabetes; however, the efficacy of HCL on glycemic and …

Background/Objective To minimize the wide spread of coronavirus disease (COVID-19)
pandemic, Italy was placed in an almost complete lockdown state that forced people to “stay …

Objective To evaluate if the lowest target level for glycated haemoglobin (HbA 1c) of< 6.5%
is associated with lower risk for retinopathy and nephropathy than less tight control in …

Abstract Purpose of Review Epidemiological research on type 1 diabetes (T1D) has
traditionally focussed on the paediatric age group, but recent data in adults has confirmed it …